Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2007

01.07.2007 | Hepatic and Pancreatic

Recurrence and Survival Outcomes after Hepatic Resection with or without Cryotherapy for Liver Metastases from Colorectal Carcinoma

verfasst von: Rui Niu, BSc (Med), Tristan D. Yan, BSc (Med), MBBS, Jacqui C. Zhu, BSc (Med), Deborah Black, BSc, DipEd, MStat, PhD, Francis Chu, MBBS, David L. Morris, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Some reports support resection combined with cryotherapy for patients with multiple bilobar colorectal liver metastases (CRLM) that would otherwise be ineligible for curative treatments. This series demonstrates long-term results of 415 patients with CRLM who underwent resection with or without cryotherapy.

Methods

Between April 1990 and January 2006, 291 patients were treated with resection only and 124 patients with combined resection and cryotherapy. Recurrence and survival outcomes were compared. Kaplan-Meier and Cox-regression analyses were used to identify significant prognostic indicators for survival.

Results

Median length of follow-up was 25 months (range 1–124 months). The 30-day perioperative mortality rate was 3.1%. Overall median survival was 32 months (range 1–124 months), with 1-, 3- and 5-year survival values of 85%, 45% and 29%, respectively. The overall recurrence rates were 66% and 78% for resection and resection/cryotherapy groups, respectively. For the resection group, the median survival was 34 months, with 1-, 3- and 5- year survival values of 88%, 47% and 32%, respectively. The median survival for the resection/cryotherapy group was 29 months, with 1-, 3- and 5-year survival values of 84%, 43% and 24%, respectively (P = 0.206). Five factors were independently associated with an improved survival: absence of extrahepatic disease at diagnosis, well- or moderately-differentiated colorectal cancer, largest lesion size being 4 cm or less, a postoperative CEA of 5 ng/ml or less and absence of liver recurrence.

Conclusions

Long-term survival results of resection combined with cryotherapy for multiple bilobar CRLM are comparable to that of resection alone in selected patients.
Literatur
1.
Zurück zum Zitat Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94(7):982–999PubMedCrossRef Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94(7):982–999PubMedCrossRef
2.
Zurück zum Zitat Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12(7):887–894PubMedCrossRef Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12(7):887–894PubMedCrossRef
3.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235(6):759–766PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235(6):759–766PubMedCrossRef
4.
Zurück zum Zitat Shah SA, Haddad R, Al-Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006; 202(3):468–475PubMedCrossRef Shah SA, Haddad R, Al-Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006; 202(3):468–475PubMedCrossRef
5.
Zurück zum Zitat Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228(2):201–208PubMedCrossRef Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228(2):201–208PubMedCrossRef
6.
Zurück zum Zitat Yan DB, Clingan P, Morris DL. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? Cancer 2003; 98(2):320–330PubMedCrossRef Yan DB, Clingan P, Morris DL. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? Cancer 2003; 98(2):320–330PubMedCrossRef
7.
Zurück zum Zitat Shafir M, Shapiro R, Sung M, et al. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996; 171(1):27–31PubMedCrossRef Shafir M, Shapiro R, Sung M, et al. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996; 171(1):27–31PubMedCrossRef
8.
Zurück zum Zitat Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43(3):141–154PubMed Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43(3):141–154PubMed
9.
Zurück zum Zitat Gruenberger T, Jourdan JL, Zhao J, et al. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136(10):1154–1157PubMedCrossRef Gruenberger T, Jourdan JL, Zhao J, et al. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136(10):1154–1157PubMedCrossRef
10.
Zurück zum Zitat Yan TD, Padang R, Xia H, et al. Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve long-term survival. Am J Surg 2006; 191(6):735–742PubMedCrossRef Yan TD, Padang R, Xia H, et al. Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve long-term survival. Am J Surg 2006; 191(6):735–742PubMedCrossRef
11.
Zurück zum Zitat Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg 1997; 225(2):193–201 Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg 1997; 225(2):193–201
12.
Zurück zum Zitat Heslin MJ, Medina-Franco H, Parker M, et al. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg 2001; 136(3):318–323PubMedCrossRef Heslin MJ, Medina-Franco H, Parker M, et al. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg 2001; 136(3):318–323PubMedCrossRef
13.
Zurück zum Zitat Finlay IG, Seifert JK, Stewart GJ, Morris DL. Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 2000; 26(3):199–202PubMedCrossRef Finlay IG, Seifert JK, Stewart GJ, Morris DL. Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 2000; 26(3):199–202PubMedCrossRef
14.
Zurück zum Zitat Hewitt PM, Dwerryhouse SJ, Zhao J, Morris DL. Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection. J Surg Oncol 1998; 67(2):112–116PubMedCrossRef Hewitt PM, Dwerryhouse SJ, Zhao J, Morris DL. Multiple bilobar liver metastases: cryotherapy for residual lesions after liver resection. J Surg Oncol 1998; 67(2):112–116PubMedCrossRef
15.
Zurück zum Zitat Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226(6):704–711PubMedCrossRef Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226(6):704–711PubMedCrossRef
16.
Zurück zum Zitat Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26(11):1333–1341PubMedCrossRef Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26(11):1333–1341PubMedCrossRef
17.
Zurück zum Zitat Stewart GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995; 32(3):215–219PubMedCrossRef Stewart GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995; 32(3):215–219PubMedCrossRef
18.
Zurück zum Zitat Ravikumar TS, Steele G, Jr., Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 1991; 51:6323–6327PubMed Ravikumar TS, Steele G, Jr., Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 1991; 51:6323–6327PubMed
19.
Zurück zum Zitat McCall JL, Jorgensen JO, Morris DL. Hepatic artery chemotherapy for colorectal liver metastases. Aust N Z J Surg 1995; 65(6):383–389PubMed McCall JL, Jorgensen JO, Morris DL. Hepatic artery chemotherapy for colorectal liver metastases. Aust N Z J Surg 1995; 65(6):383–389PubMed
20.
Zurück zum Zitat Yan TD, Padang R, Morris DL. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 2006; 202(1):100–111PubMedCrossRef Yan TD, Padang R, Morris DL. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 2006; 202(1):100–111PubMedCrossRef
21.
Zurück zum Zitat Bakalakos EA, Kim JA, Young DC, Martin EW, Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 1998; 22(4):399–404PubMedCrossRef Bakalakos EA, Kim JA, Young DC, Martin EW, Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 1998; 22(4):399–404PubMedCrossRef
22.
Zurück zum Zitat Aldrighetti L, Castoldi R, Di Palo S, et al. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Chir Ital 2005; 57(5):555–570PubMed Aldrighetti L, Castoldi R, Di Palo S, et al. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Chir Ital 2005; 57(5):555–570PubMed
23.
Zurück zum Zitat Tomizawa N, Ohwada S, Ogawa T, et al. Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer. Hepatogastroenterology 2006; 53(67):89–93PubMed Tomizawa N, Ohwada S, Ogawa T, et al. Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer. Hepatogastroenterology 2006; 53(67):89–93PubMed
24.
Zurück zum Zitat Taylor M, Forster J, Langer B, et al. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173(6):467–471PubMedCrossRef Taylor M, Forster J, Langer B, et al. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173(6):467–471PubMedCrossRef
25.
Zurück zum Zitat Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–321PubMedCrossRef Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–321PubMedCrossRef
26.
Zurück zum Zitat Moroz P, Salama PR, Gray BN. Resecting large numbers of hepatic colorectal metastases. Aust N Z J Surg 2002; 72(1):5–10CrossRef Moroz P, Salama PR, Gray BN. Resecting large numbers of hepatic colorectal metastases. Aust N Z J Surg 2002; 72(1):5–10CrossRef
27.
Zurück zum Zitat Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13(5):668–676PubMedCrossRef Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13(5):668–676PubMedCrossRef
28.
Zurück zum Zitat Biasco G, Derenzini E, Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006; 32(3):214–228PubMedCrossRef Biasco G, Derenzini E, Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006; 32(3):214–228PubMedCrossRef
29.
Zurück zum Zitat Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13(10):1261–1268PubMedCrossRef Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13(10):1261–1268PubMedCrossRef
30.
Zurück zum Zitat Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239(5):722–730PubMedCrossRef Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239(5):722–730PubMedCrossRef
31.
Zurück zum Zitat Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137(6):675–680PubMedCrossRef Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137(6):675–680PubMedCrossRef
32.
Zurück zum Zitat Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg 1997; 63(7):605–610PubMed Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg 1997; 63(7):605–610PubMed
33.
Zurück zum Zitat Milandri C, Calzolari F, Giampalma E, et al. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 2003; 89(Suppl 4):112–114 Milandri C, Calzolari F, Giampalma E, et al. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 2003; 89(Suppl 4):112–114
34.
Zurück zum Zitat Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13(10):1271–1280PubMedCrossRef Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13(10):1271–1280PubMedCrossRef
35.
Zurück zum Zitat Golling M, Gog C, Woeste G, et al. Colorectal cancer liver metastases—neoadjuvant concepts for preoperative down-sizing. Zentralbl Chir 2006; 131(2):140–147PubMedCrossRef Golling M, Gog C, Woeste G, et al. Colorectal cancer liver metastases—neoadjuvant concepts for preoperative down-sizing. Zentralbl Chir 2006; 131(2):140–147PubMedCrossRef
36.
Zurück zum Zitat Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240(4):644–657PubMed Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240(4):644–657PubMed
37.
Zurück zum Zitat Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240(6):1052–1061PubMedCrossRef Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240(6):1052–1061PubMedCrossRef
38.
Zurück zum Zitat Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004; 15(6):933–939PubMedCrossRef Pozzo C, Basso M, Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004; 15(6):933–939PubMedCrossRef
39.
Zurück zum Zitat Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8(4):347–353PubMedCrossRef Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8(4):347–353PubMedCrossRef
40.
Zurück zum Zitat Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224(4):509–520PubMedCrossRef Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224(4):509–520PubMedCrossRef
41.
Zurück zum Zitat Capussotti L, Muratore A, Mulas MM, et al. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 2006; 93(8):1001–1006PubMedCrossRef Capussotti L, Muratore A, Mulas MM, et al. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 2006; 93(8):1001–1006PubMedCrossRef
42.
Zurück zum Zitat Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours—a practical guide. HPB Surg 1995; 8(3):167–173PubMed Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours—a practical guide. HPB Surg 1995; 8(3):167–173PubMed
Metadaten
Titel
Recurrence and Survival Outcomes after Hepatic Resection with or without Cryotherapy for Liver Metastases from Colorectal Carcinoma
verfasst von
Rui Niu, BSc (Med)
Tristan D. Yan, BSc (Med), MBBS
Jacqui C. Zhu, BSc (Med)
Deborah Black, BSc, DipEd, MStat, PhD
Francis Chu, MBBS
David L. Morris, MD, PhD
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9400-1

Weitere Artikel der Ausgabe 7/2007

Annals of Surgical Oncology 7/2007 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.